Gerard J Michel
CIK 1235644 · CHIEF EXECUTIVE OFFICER · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VCEL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SALT LAKE CITY, UT 84108
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBNX | Director | 33,509 | $16.71 | $559.9K | $0 | 3 | 2026-05-26 |
| DCTH | CHIEF EXECUTIVE OFFICER | 342,034 | $14.02 | $4.79M | $1.47M | 23 | 2026-03-03 |
| VCEL | CFO and VP, Corp. Development | 253,865 | $40.79 | $10.36M | -$2.86M | 23 | 2020-04-03 |
| Vericel Corp (ASTM) Delisted | CFO and VP, Corp. Development | 20,000 | — | — | $51.0K | 1 | 2014-09-17 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | CFO, VP of Corp and Dev/Treas | 1,522 | — | — | -$8.2K | 13 | 2014-03-14 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | CFO & VP, Corp. Development | — | — | — | $0 | 4 | 2007-10-16 |
| EP MEDSYSTEMS INC (EPMD) Delisted | Director | — | — | — | $0 | 1 | 2007-01-11 |
Recent Filings · Page 4 of 7
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-16 | VCEL | Mixed | — | -$231.2K | EDGAR |
| 2019-07-17 | VCEL | Mixed | — | -$283.2K | EDGAR |
| 2019-06-12 | VCEL | Mixed | — | -$222.9K | EDGAR |
| 2019-05-14 | VCEL | Mixed | — | -$249.7K | EDGAR |
| 2019-04-10 | VCEL | Mixed | — | -$225.2K | EDGAR |
| 2019-03-12 | VCEL | Sell (S) | −10,000 | -$200.2K | EDGAR |
| 2019-02-13 | VCEL | Sell (S) | −10,000 | -$170.9K | EDGAR |
| 2019-02-08 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2019-01-16 | VCEL | Sell (S) | −8,711 | -$149.6K | EDGAR |
| 2018-12-12 | VCEL | Mixed | — | -$228.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.